Juna

Spring, United States Founded: 2021 • Age: 5 yrs
At-home STI testing and clinical support services are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About Juna

Juna is a company based in Spring (United States) founded in 2021 by Kyle H and Peter Arian. It operates as a Subscription Services. Juna offers products and services including Semaglutide Injection, Semaglutide Oral, and Tirzepatide Injection. Juna operates in a competitive market with competitors including imaware, Virex, Oral Genome, STDAssessment and Real Rads, among others.

  • Headquarter Spring, United States
  • Founders Kyle H, Peter Arian
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Juna

Juna offers a comprehensive portfolio of products and services, including Semaglutide Injection, Semaglutide Oral, and Tirzepatide Injection.

Product name locked
Category locked
Primary

Semaglutide injection is provided for weight loss treatment.

Product name locked
Category locked
Locked

Semaglutide oral tablets are offered for weight management.

Product name locked
Category locked
Locked

Tirzepatide injection is used for effective weight reduction.

People of Juna

Headcount 1-10
Employee Profiles 3
Employee Profiles
People
Peter Arian
Chief Executive Officer
People
Nilan Saha
Co-founder & CTO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Juna

Premium access

Detailed funding history for Juna

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Juna

Investments
Premium access

Investment portfolio details for Juna

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Juna

Premium access

Detailed financials for Juna

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Juna Comparisons

Juna Primary company
Description
At-home STI testing and clinical support services are provid...
Location
Spring, United States
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Juna

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Juna

Juna operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as imaware, Virex, Oral Genome, STDAssessment and Real Rads, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Platform for personalized health data and diagnostic testing is provided.
Locked Locked Locked
Diagnostics services are provided at home by Virex.
Locked Locked Locked
Personalized oral care kits are provided for individual needs.
Locked Locked Locked
Delivers comprehensive internet-based clinical lab solutions for STD and other disease treatments.
Locked Locked Locked
Offers remote radiology services with fast image reading for hospitals and radiologists.
Premium access

Detailed competitors of Juna

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Juna

Premium access

Complete news archive for Juna

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Juna

Juna was founded in 2021.

Juna is headquartered in Spring, United States. It is registered at Spring, Texas, United States.

Peter Arian is the current CEO of Juna. They have also founded this company.

Juna is engaged in offering health solutions specifically targeting weight loss through medications like Semaglutide and Tirzepatide. Services are provided in multiple U.S. states including Arizona, Florida, and New York. Compounded medications are sourced from FDA-registered pharmacies adhering to strict quality standards. Support is extended through unlimited doctor visits and 247 clinical assistance. The focus is placed on ensuring safety and effectiveness for patients seeking significant weight reduction.

Juna's top competitors include imaware, Oral Genome and Virex.

Juna offers Semaglutide Injection, Semaglutide Oral, and Tirzepatide Injection.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available